Search

everythinglearnresearchcommunity

for

Search:↓

Male Androgenetic Alopecia, a common hair loss in men, can be slowed and partially restored with treatments like minoxidil and finasteride, or hair transplantation. Serenoa repens may be an alternative treatment. More research is needed for new treatments.

Cyanidin 3-O-arabinoside may help treat a common form of hair loss by protecting cells against aging and improving cell function.

Two drugs, finasteride and minoxidil, are approved for hair loss treatment, but new therapies are being developed.

Men who start losing hair at age 30 may have a lower risk of prostate cancer.

Treating hair loss in both men and women is effective and improves quality of life.

DNA methylation changes in women with PCOS could be used as disease markers and suggest new treatment targets.

Stem cell therapies could be a promising alternative for hair loss treatment, but more research is needed to understand their full potential and safety.

Hair loss can be managed with treatments like minoxidil, finasteride, and others, but there are still gaps in effectiveness and off-label usage is increasing.

Oxidative stress worsens PCOS by damaging cells and disrupting metabolism, suggesting antioxidant treatments might help.

Dermoscopy is an effective tool for accurately detecting skin cancers.

Spironolactone improved cognitive performance and early sleep quality but not manic symptoms, appetite, or body weight in bipolar disorder when added to sodium valproate.

Sons of mothers with polycystic ovary syndrome (PCOS) have a higher risk of obesity and insulin resistance, possibly due to certain genes and factors passed down from their mothers.

Changes in gut bacteria can contribute to the development of Polycystic Ovary Syndrome (PCOS), affecting metabolism, immunity, and causing inflammation. Treatments may involve adjusting these factors.

Men with early balding showed higher levels of certain genes linked to hair loss and possibly prostate cancer.

Nanocarriers with plant extracts show promise for safe and effective hair growth treatment.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

Curcuma aeruginosa Roxb. may help treat hair loss by affecting specific biological pathways.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Enhancers and super-enhancers are key in controlling specific gene activity and can play a role in cancer development.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

The research confirms that Hidradenitis Suppurativa is characterized by increased inflammation, disrupted skin cell organization, and abnormal metabolic processes.

The study identified 12 potential biomarkers for hair loss and how they affect hair growth.

Different ACE2 gene versions may affect COVID-19 impact based on age and suggest some hair loss drugs could be potential treatments.

Certain changes in the VEGF gene can increase or decrease the risk of polycystic ovary syndrome.

The study concludes that regulating apoptosis could lead to new treatments for various skin and hair conditions.

Hormonal imbalances during menopause may significantly contribute to Frontal Fibrosing Alopecia.

Treating hair loss effectively may require a multi-sided approach, using different treatments together, and topical treatments could be more effective and safer than oral ones.